AI-powered earnings analysis with management quotes, bull/bear cases, and financial breakdowns for 400+ public companies.
GSK's earnings surge and resilient pipeline provide hope despite looming HIV headwinds.
Johnson Controls shows strength with solid growth, but the sustainability debate may leave investors feeling a bit chilled.
Eli Lilly flexes its muscles with a 42.6% revenue jump, but can it dodge pricing pressures ahead?
With rising revenue but falling stock, MetLife faces a tightrope walk on sustainability and growth.
Markel demonstrates resilience, but can they keep the win streak alive amid softening markets?
With mixed signals on Remibrutinib, can Novartis balance growth and trial turbulence?
O'Reilly’s growth clashes with rising costs, leaving investors in the slow lane of uncertainty.
With revenue at $34.1B, PSX shines but bears brace for sustainability questions.
As PTC thrives on smart product innovation, the challenge of deferred ARR looms large.
Qualcomm's earnings show growth, but DRAM shortages put a serious dent in the handset horizon.
Snap's earnings reveal a struggle between growth and profit, leaving investors in a state of snap-shock.
StoneX shines bright amid market volatility, but can its dazzling earnings power survive integration hurdles?
With a 29.4% revenue boost, Symbotic navigates both promise and peril in its quest for AI-driven success.
Despite strong revenue growth, fears of AV roadblocks leave Uber's stock spinning its wheels.
ADM's revenue dip raises questions about biofuel futures and market resilience amid rising costs and demand challenges.
AMD’s Q4 stumble raises questions about its AI ambitions—can it regain momentum before the competition catches up?
Amgen's Q4 earnings show that Meritide is the real heavyweight in the obesity ring, but beware of competitive jabs!
Chubb's solid growth masks looming pricing pressures and regulatory challenges.
With 4.9% growth, Chipotle serves up a spicy mix of optimism and concern for the year ahead.
With revenue down and stock sliding, Corteva's harvest of hopes faces tough weather ahead.
With a dazzling 38.6% stock surge, can Enphase outsmart the tariff storm?
EPD's earnings surge masks caution over future growth amidst commodity concerns.
Eaton's earnings light the fuse on AI growth but execution risks loom large.
Despite solid growth, Intapp's stock nosedives as AI promise turns into a high-stakes debate over durability and monetization.